NCT04877925

Brief Summary

Objectives: Chest tubes are routinely inserted after thoracic surgery procedures in different size and numbers. The aim of this study is to assess the efficacy of Smart Drain Coaxial drainage compared with two standard chest tubes in patients undergoing thoracotomy for pulmonary lobectomy. 98 patients (57 males and 41 females, mean age 68.3±7.4 years) with lung cancer undergoing open pulmonary lobectomy were randomized in two groups: 50 received one upper 28-Fr and one lower 32-Fr standard chest tube (ST group) and 48 received one 28-Fr Smart Drain Coaxial tube (CT group). Hospitalization data, quantity of fluid output, air leaks, radiograph findings, pain control and costs were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

1.2 years

First QC Date

April 27, 2021

Last Update Submit

May 6, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Daily fluid drainage (mL)

    Quality of fluid drainage evaluated in mL and by means of a chest X rays

    1 postoperative day

  • Presence of postoperative pneumothorax

    Quality of air drainage evaluated by chest X rays

    1 postoperative day

Secondary Outcomes (4)

  • presence of pneumothorax after tubes removal

    within 24 hours after tubes removal

  • evaluation of pain measured by Visual Analogue Scale

    1 postoperative day

  • Analysis of costs (in euros)

    until discharge, an average of 6 days

  • Postoperative hospitalization (in days)

    until discharge, an average of 6 days

Study Arms (2)

Standard Group

ACTIVE COMPARATOR

Patients with 2 standard chest tubes

Device: standard chest tubes

Coaxial Group

EXPERIMENTAL

Patients with 1 coaxial tube

Device: coaxial chest tube

Interventions

2 standard postoperative chest tube used

Standard Group

1 postoperative smart drain coaxial tube

Coaxial Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age more than 18 years
  • patients scheduled for pulmonary lobectomy

You may not qualify if:

  • middle lobectomy,
  • extended resections, minimally invasive lobectomies,
  • previous ipsilateral thoracic surgery,
  • induction chemo and/or radiotherapy
  • patients who did not give consent to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sapienza University of Rome

Roma, Italy

Location

Related Publications (2)

  • Guerrera F, Filosso PL, Pompili C, Olivetti S, Roffinella M, Imperatori A, Brunelli A. Application of the coaxial smart drain in patients with a large air leak following anatomic lung resection: a prospective multicenter phase II analysis of efficacy and safety. J Vis Surg. 2018 Jan 29;4:26. doi: 10.21037/jovs.2018.01.07. eCollection 2018.

  • Rena O, Parini S, Papalia E, Massera F, Turello D, Baietto G, Casadio C. The Redax(R) Coaxial Drain in pulmonary lobectomy: a study of efficacy. J Thorac Dis. 2017 Sep;9(9):3215-3221. doi: 10.21037/jtd.2017.08.110.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 27, 2021

First Posted

May 7, 2021

Study Start

February 1, 2017

Primary Completion

April 30, 2018

Study Completion

November 30, 2020

Last Updated

May 7, 2021

Record last verified: 2021-05

Locations